Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
not enough coffee. $OCLS renamed to $SNOA
Oculus Innovative Sciences Higher Off Sale Of Latin America Unit
http://tinyurl.com/gpb6qng
CFO [presented well at Aegis Health Care conf. this week. I like the skin care line. Removes scarring.
of course. 5:1
has the reverse split happened yet?
Only little in red now.
Perhaps green end of day, lol.
i like it.
cheap shares now.
after reverse split this is going up.
My experience a R/S is never good for anyone except the very top of the company. Share holders are left holding a much smaller and less valuable BAG!
I hate those reverse splits I'm out
this is very good.
You'll see it this Friday.. lol. Reverse Split announced.
http://seekingalpha.com/news/3189990-oculus-reverse-split-shares-1-5-june-24
Yes, numbers are good.
End of year we will see a share price between 1.50 and 2.00 $
Sounds good to me now we just have to wait for it to sink in to the masses
http://finance.yahoo.com/news/oculus-innovative-sciences-reports-financial-200500067.html
Product Revenue for Fiscal Year 2016 Grew 31% Led by Growth in U.S.
fiscal year and fourth quarter 2016, ended March 31, 2016, will be released after the
https://globenewswire.com/news-release/2016/06/02/845498/0/en/Oculus-Innovative-Sciences-Announces-Financial-Results-for-the-Fiscal-Year-Fourth-Quarter-2016-and-Conference-Call.html
If we see good price movement and volume in the short term, I'll fall on the sword and agree till then.....
But this was a good verdict.
Not a good verdict, but willing to give it sometime to see what develops.
What's the verdict?
News: Oculus Innovative Sciences Launches New Ceramax™ Skin Barrier Cream in the United States
https://finance.yahoo.com/news/oculus-innovative-sciences-launches-ceramax-080500048.html
PETALUMA, Calif., May 03, 2016 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (NASDAQ: OCLS, warrants OCLSW), a specialty pharmaceutical company that develops and markets solutions for the treatment of dermatological conditions and advanced tissue care, today announced the launch of Ceramax™ Skin Barrier Cream, intended to be used as a topical skin care preparation to relieve and to manage the burning and itching associated with various dermatoses including atopic dermatitis, irritant contact dermatitis, radiation dermatitis and other dry skin conditions.
I agree, just will have to wait and see what comes out of the conference.
OCLS seems to be stuck here like stuco,the pr was a dud.imo
Oculus Innovative Sciences to Present at Pioneers 2016 Investor Conference Hosted by Joseph Gunnar & Company in New York City
Oculus Presentation on Thursday, May 5, 2016 at 2:00 pm EDT
You can do that only on OTC stocks not on NASDAQ
The real NASDAQ has no clue that this stock even exists, let alone an opinion on it. This article is all paid for hype from the pump and dump pros.
Come back on this date when Investor Conference, to be held on May 3-5, 2016 OCLS is going to fly better to load up now.
Oculus Innovative Sciences to Present at the Third Annual Growth Capital Expo MicroCap Investor Conference in Las Vegas
Oculus Presentation on Wednesday, May 4, 2016 at 10:00 am PDT
PETALUMA, Calif., April 27, 2016 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) (NASDAQ:OCLSW), a specialty pharmaceutical company that develops and markets solutions for the treatment of dermatological conditions and advanced tissue care, today announced that Jim Schutz, the company's CEO, will present a corporate overview and business update at the Third Annual Growth Capital Expo MicroCap Investor Conference, to be held on May 3-5, 2016 at Caesars Palace in Las Vegas. The Oculus presentation is scheduled on Wednesday, May 4, 2016, at 10:00 am PDT, with a breakout session to immediately follow.
For those interested in attending the Oculus presentation, registration is still open at www.growthcapitalexpo.com/register-2/.
About the Growth Capital Conference
The Growth Capital Expo is the premier conference for emerging growth company finance featuring:
•Presentations by selected MicroCap and pre-IPO growth company management teams showcasing the best opportunities of the year for emerging growth investment.
•Two full days of educational panels and presentations by the leading practitioners of investment in public and late-stage private emerging growth companies as well as a half-day educational pre-conference for executive managers of pre-IPO and recently public companies.
About Oculus Innovative Sciences, Inc.
Oculus Innovative Sciences is a specialty pharmaceutical company that develops and markets solutions for the treatment of dermatological conditions and advanced tissue care. The company's products, which are sold throughout the United States and internationally, have improved outcomes for more than five million patients globally by reducing infections, itch, pain, scarring and harmful inflammatory responses. The company's headquarters are in Petaluma, California, with manufacturing operations in the United States and Latin America. European marketing and sales are headquartered in Roermond, Netherlands. More information can be found at www.oculusis.com.
Forward-Looking Statements
Except for historical information herein, matters set forth in this press release are forward-looking within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, including statements about the commercial and technology progress and future financial performance of Oculus Innovative Sciences, Inc. and its subsidiaries (the "Company"). These forward-looking statements are identified by the use of words such as "present," and "scheduled," among others. Forward-looking statements in this press release are subject to certain risks and uncertainties inherent in the Company's business that could cause actual results to vary, including such risks that regulatory clinical and guideline developments may change, scientific data may not be sufficient to meet regulatory standards or receipt of required regulatory clearances or approvals, clinical results may not be replicated in actual patient settings, protection offered by the Company's patents and patent applications may be challenged, invalidated or circumvented by its competitors, the available market for the Company's products will not be as large as expected, the Company's common stock and warrants may be delisted from NASDAQ, the Company's products will not be able to penetrate one or more targeted markets, revenues will not be sufficient to fund further development and clinical studies, the Company may not meet its future capital needs, the Company may not be able to obtain additional funding, as well as uncertainties relative to varying product formulations and a multitude of diverse regulatory and marketing requirements in different countries and municipalities, and other risks detailed from time to time in the Company's filings with the Securities and Exchange Commission including its annual report on Form 10-K for the year ended March 30, 2015. The Company disclaims any obligation to update these forward-looking statements, except as required by law.
Oculus® and Microcyn® Technology are trademarks or registered trademarks of Oculus Innovative Sciences, Inc. All other trademarks and service marks are the property of their respective owners.
Media and Investor Contact:
Oculus Innovative Sciences, Inc.
Dan McFadden
VP of Public and Investor Relations
(425) 753-2105
dmcfadden@oculusis.com
$2.00 ??
The news are not good enough.
We are in red, lol.
You better be selling right niw
Didn't I told you we will see good news this week we had one yesterday and one today, here is another great news that is out today we might see OCLS at $2.00 this week or even today.
Oculus Innovative Sciences to Present at the Third Annual Growth Capital Expo MicroCap Investor Conference in Las Vegas
http://finance.yahoo.com/news/oculus-innovative-sciences-present-third-080500825.html
I will be out long before that. I don't need it to hit 1.14
Yea I'll be here to see what's going on. I wouldn't celebrate too quick if I were you. There's a clear downtrend line and I doubt this will get past 1.14, if it even makes it that high
Will you be around on Fri?
Depends. How close are you launching from?
We are headed to the moon.
The seller or same mm has now become the buyer. The bid sizes tell you which way it will be headed.
Low volume, but slowly we are moving up.
Yes, but once the cheap shares, seller who doesn't care at what price they sell, dry up then it will slowly move up. Today it only took $70k to bring the price this far down. They are not... Watch the asks on level II.
i think we need more buyers.
This we will only get with big news.
No, we need the seller to be done. It looks as if they are done or taking a break
So we need much better news to get a trend in green.
Some strong seller is there. Until they are done unloading the trend will not xhange
News and this paper is going to get more red.
Not good.
The way it is going you maybe on target
Yes multiply that by the pps. Not much right? Compare to yesterday by this time.
No volume ? I see volume.
Volume: 18,093
How did you arrive at that target?
Followers
|
25
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
524
|
Created
|
09/16/07
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |